Finzati - Logo
TAOX logo

TAO Synergies Inc.

TAOX • Biotechnology
$3.88
▼ -0.17 (-4.07%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$29.91M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 13.99Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 13, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:33 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$3.89
Change-4.07%
Shares Out7.70M
Market Cap$29.91M
Enterprise Value$1.11M
52W Range3.18 - 10.00
Beta1.47
P/E-1.20
P/S43.49
P/B1.14
P/FCF-4.92
EV/Sales1.61

Investment DNA

How strong this company looks for long-term investors

40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 13.99Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 7/2/2025
Industry: Biotechnology
P/B i: 1.14
Debt / Equity i: 0.00
Operating Margin: -3025.19%
Net Margin: -9609.23%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 13.99
Quick Ratio: 13.99
Status: Good

Insider Transactions

Recent executive and insider activity

Ephron Robert
Transaction: 05/18/2026
BUY
Change
+10,000
Price
$4.80
Filing
05/19/2026
Type
BUY
WEINSTEIN ROBERT
Transaction: 05/18/2026
BUY
Change
+30,000
Price
$4.80
Filing
05/19/2026
Type
BUY
Singer William S.
Transaction: 05/18/2026
BUY
Change
+35,000
Price
$4.80
Filing
05/19/2026
Type
BUY